50
Views
1
CrossRef citations to date
0
Altmetric
Corrigendum

Budget impact analysis of the simplification to atazanavir + ritonavir + lamivudine dual therapy of HIV-positive patients receiving atazanavir-based triple therapies in Italy starting from data of the Atlas-M trial [Corrigendum]

Page 231 | Published online: 19 Apr 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Umberto Restelli, Massimiliano Fabbiani, Simona Di Giambenedetto, Carmela Nappi & Davide Croce. (2017) Update of the budget impact analysis of the simplification to atazanavir + ritonavir + lamivudine dual therapy of HIV-positive patients receiving atazanavir-based triple therapies in Italy starting from data of the Atlas-M trial. ClinicoEconomics and Outcomes Research 9, pages 569-571.
Read now